UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Tegretol-20mgml-Suspension-SE-AJ-RA

Generated Narrative: RegulatedAuthorization Tegretol-20mgml-Suspension-SE-AJ-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/9115

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100003469-00009115,http://ema.europa.eu/fhir/eurdId#539; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Oral suspension; indication = Epilepsier. Generaliserade toniska-kloniska anfall (grand mal). Partiella anfall. Karbamazepin är ej verksamt vid absenser (petit mal). Trigeminusneuralgi. Alkoholabstinens.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = carbamazepine

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 1975-10-08

holder: Organization Novartis Sverige AB

Cases

-TypeDate[x]
*First Authorisation1975-10-08